Nektar Therapeutics | NKTR - Passifs Courants





Passifs Courants Changement Date
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
ALKERMES USD 599.5M 56.06M 2026-03
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 24.96B 534M 2026-03
Baxter International USD 3.69B 723M 2026-03
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Biogen USD 3B 350.5M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Cara Therapeutics USD 11.04M 362K 2025-09
Cipla INR 62.97B 8.13B 2025-09
Dr.Reddys Laboratories INR 158.31B 7.38B 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Merck USD 26.94B 1.38B 2026-03
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Xencor USD 95.91M 9.42M 2025-12